BOGER DALE L has a total of 23 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LYSOSOMAL THERAPEUTICS INC, BAYER YAKUHIN LTD and ZHEJIANG BETA PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 13 | |
#2 | United States | 10 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Boger Dale L | 23 |
#2 | Wirsching Peter | 1 |
#3 | Janda Kim D | 1 |
#4 | Wilson Ian A | 1 |
Publication | Filing date | Title |
---|---|---|
US2011183947A1 | Alpha-keto heterocycles as FAAH inhibitors | |
WO2009154785A2 | C4-substituted alpha-keto oxazoles | |
US2010075931A1 | Substituted oxazole ketone modulators of fatty acid amide hydrolase | |
WO2007084507A2 | [ψ[CH2NH]PG4] GLYCOPEPTIDE ANTIBIOTIC ANALOGS | |
WO2006002895A2 | Conjugates of antibody and duoarmycin derivatives as antitumor agents | |
WO2004101767A2 | Cbi analogues of the duocarmycins and cc-1065 |